🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Insiders Buying Dorian LPG And 2 Other Stocks

Published 17/01/2024, 11:23
© Reuters.  Insiders Buying Dorian LPG And 2 Other Stocks
AVDL
-
LPG
-
KALV
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Although U.S. stocks closed lower on Tuesday, there were a few notable insider trades.

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.

KalVista Pharmaceuticals

  • The Trade: KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) 10% owner Nimish Shah acquired a total of 26,246 shares an average price of $12.72. To acquire these shares, it cost around $333,779.
  • What’s Happening: KalVista Pharma, last month, announced publication of first oral factor XIIa data in Frontiers in Pharmacology.
  • What KalVista Pharmaceuticals Does: KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases.
Avadel Pharmaceuticals
  • The Trade: Avadel Pharmaceuticals plc (NASDAQ: AVDL) CFO Thomas McHugh acquired a total of 2,000 shares at an average price of $14.50. To acquire these shares, it cost around $29,000.
  • What’s Happening: Avadel said it held $105 million of cash, cash equivalents and marketable securities at Dec. 31, 2023.
  • What Avadel Pharmaceuticals Does: Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States.
Don’t forget to check out our premarket coverage here

Dorian LPG

  • The Trade: Dorian LPG Ltd. (NYSE: LPG) President and CEO John C Hadjipateras bought a total of 5,000 shares at an average price of $42.58. To acquire these shares, it cost around $212,900.
  • What’s Happening: Dorian LPG, during November, posted upbeat quarterly results.
  • What Dorian LPG Does: Dorian LPG Ltd is an international liquefied petroleum gas shipping company focused on owning and operating gas carriers, or VLGCs.

Check This Out: How To Earn $500 A Month From Alcoa Stock Ahead Of Q4 Earnings Report

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.